Evidence map›Paper›PMID 42327792›Full record

ReviewFrontiers in immunology2026

Clocking immunity: circadian modulation of NK cells and emerging timing perspectives.

Kun Liu, Xuanying Lv, Wen Wen

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kun Liu *Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Shanghai, China.
Xuanying Lv *Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Shanghai, China.
Wen WenThird Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells show day-night variation in both number and effector function. We compile findings from human cohorts, animal models, and cell studies on how circadian timing shapes NK biology. Evidence spans daily changes in counts and readouts such as degranulation and IFN-γ; links to core clock modules (PER1/2, NFIL3/E4BP4, STRA13); and neuroendocrine inputs (sympathetic tone, glucocorticoids, melatonin). Acute sleep loss can transiently raise NK activity, whereas multi-day sleep deprivation or circadian misalignment lowers counts or function. Shift work studies and laboratory night-shift simulations show reductions in NK activity and phase-sensitive changes in transcriptional programs (e.g., AP-1/STAT), with effects amplified by irregular schedules and accumulated fatigue. Across cancer, depression, vitiligo, and infection, alterations are heterogeneous, often presenting as peak shifts or amplitude flattening rather than loss of rhythmicity. Photoperiod, season, age, and sex can modify these patterns. Current data support a circadian influence on NK biology, but the direction and magnitude of reported effects vary across species, sampling schedules, circadian phase definitions, tissue compartments, and NK-cell readouts. This heterogeneity underscores the need for longitudinal, high-frequency sampling with complementary continuous monitoring to define phase, amplitude, and stability across physiological and clinical contexts.

Indexed as

Circadian ClocksCircadian RhythmKiller Cells, NaturalAnimalsHumansPhotoperiodSleep Deprivationchronotherapycircadian rhythmsdegranulationglucocorticoidsnatural killer cellsneuroendocrine regulationshift worksleep deprivation

Identifiers

PMID42327792
PMCPMC13275478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.